1. What data in particular will be shared?
   Response - All of the individual participant data collected during the trial, after de-identification.
   


2. What additional supporting information will be shared?
   Response -  Study Protocol
   
   
3. Who will be able to view these files?
   Response - Anyone
   


4. For what types of analyses will this data be available?
   Response - Any purpose.
   


5. By what mechanism will data be made available?
   Response - Proposals should be directed to [anupamaaugustine3@gmail.com].
   


6. For how long will this data be available start date provided 01-01-2026 and end date provided 31-12-2026?
   Response - Immediately following publication. No end date.
   


7. Any URL or additional information regarding plan/policy for sharing IPD? 
   Additional Information - Nil

60 patients with Type 2 diabetes mellitus and those who fulfill the inclusion and exclusion criteria will be selected for the study, 30 in control group and 30 in experimental group. The investigator will approach the subjects, explain the study purpose, establish rapport, and obtain informed consent from the subjects.

On the first day pretest for the control group will be done. Socio personal data and clinical data will be collected using socio personal data sheet. A practice checklist will be used to assess the practice regarding diabetic foot ulcer prophylaxis in the pretest. A structured knowledge questionnaire will be used to collect knowledge regarding diabetic foot ulcer prophylaxis.Control group will receive  the conventional treatment as per the hospital protocol. Post test will be conducted on the 15th day.

On the first day,pre test for the experimental group will be done. the socio-personal data and clinical data will be collected using a socio-personal and clinical data sheet. A practice checklist will be used to assess the practice regarding diabetic foot ulcer prophylaxis in the pretest .A structured knowledge questionnaire will be used to collect knowledge regarding diabetic foot ulcer prophylaxis .Thereafter, the group will receive a self-care management program, which includes an educational session regarding diabetic foot ulcer prophylaxis.

The educational session will include diabetic foot ulcers, risk factors, early manifestations, and healthy foot care practices, delivered through the lecture method for a duration of 15 minutes as an individual session.

This will be followed by a demonstration of foot ulcer prophylaxis practices, which include foot examination and practice regarding daily foot care, given for a duration of 20 minutes for each individual. Doubts regarding the self-care management program will be cleared by the researcher. Caregivers will also be motivated and reinforced to supervise these self-care management programs at home.

On the day of discharge, patients are motivated to follow the foot care prophylaxis practice daily at home. They are provided with a practice diary to record their performance every day. An information booklet will be given to the group regarding diabetic foot ulcer prophylaxis practices. Reinforcements will be given via phone call every day by the investigator. The study will be conducted when you are admitted in the medicine wards of Govt. TDMCH, Vandanam for the treatment.

A post-test will be conducted on the 15th day at OPD, when the patients came for follow up after the intervention. The total duration of data collection will be 30 minutes. The collected data will be organized, tabulated, analysed, and interpreted using descriptive and inferential statistics.